FDG PET/CT in patients with HIV

AJR Am J Roentgenol. 2011 Aug;197(2):284-94. doi: 10.2214/AJR.10.6332.

Abstract

Objective: This article will discuss the (18)F-FDG normal variant uptake and the role of FDG PET/CT in malignancies in HIV-infected patients, CNS manifestations of HIV, assessing fever of unknown origin in HIV patients, assessing response to highly active antiretroviral therapy and assessing complications.

Conclusion: FDG PET/CT is a valuable imaging study in the management of HIV-infected patients.

Publication types

  • Review

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • Central Nervous System / diagnostic imaging
  • Disease Progression
  • Fever of Unknown Origin / diagnostic imaging
  • Fever of Unknown Origin / etiology
  • Fluorodeoxyglucose F18* / pharmacokinetics
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Humans
  • Neoplasms / diagnostic imaging
  • Neoplasms / etiology
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals* / pharmacokinetics
  • Tomography, X-Ray Computed / methods*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18